Article Sidebar
Views PDF: 213
The responsiveness of the uterine fibroid symptom after Uterine artery embolization for the treatment of Uterine fibroids with health-related quality of life questionnaire (UFS-QOL)
Main Article Content
Abstract
Purpose: The responsiveness of the uterine fibroid symptom after Uterine artery embolization for the treatment of Uterine fibroids with healthrelated quality of life questionnaire (UFS-QOL).
Method and objective: Follow- up study from January 2019 to July 2020, we treated 36 patients who manifest symptom cliniclly (mean 38,08±6.26 year, range 24-59 years). quality of life test before and after treatment for 3 months and 6 months. The find the relationship between treatment outcomes and quality of life.
Results: A total of 36 patients with 43 tumors received the intervention, a technical success rate of 100%. Clinically, after 6 months, 80% of patients
stopped menorrhagia, 85,7% of patients had stopped abdominal pain, the mean tumor volume decreased after 3 months and% after 6 months (p <0.05).
Quality of life score improved 42 points after 6 months.
Conclusion: Uterine fibroid embolization seems to lead to notable long-term relief of fibroid- associated symptoms. In comparison with the midterm results, long-term outcome shows a clear continuance of improvement in general quality of life
Article Details
Keywords
fibroid, Uterine artery embolization, quality of life
References
2. Fallowfield L. “What is quality of life? 2nd edition, Hayward Medical Communications, Sussex . 2009 .https://doi.org/10.1016/j.clon.2008.11.003
3. Velikova G., Coens c., Efficace F. et al Health-related quality of life in EORTC clinical trials — 30 years of progress from methodological developments to making a real impact on oncology practice. Eur J Cữ.suppl 10(1), 141-149.2012.
4. Fairclough D.L.Quality of life, cancer investigation and clinical practice. Ca Investigation, 16(7),478-484.1998..
5. Varicchio C.G, Ferrans C.E Quality of life assessment in clinical practice. Semitì Oncol Nursing, 26(1), 12-17.2010.
6. Fitzpatrick R., Fletcher A., Gore s. et al .Quality of life measures in health care. I: Applications and issues in assessment. BMJ, 305,1074-1077.1992.
7. Vũ Nhật Thăng “U xơ tử cung. Bài giảng Sản Phụ”, Nhà xuất bản Y học: 290-299.2004.
8. Fiona M. Fennessy, MD, PhD Chung Yin Kong, PhD Clare M. Tempany, MD J. Shannon Swan, MD “Quality-ofLife Assessment of Fibroid Treatment Options and Outcomes” Radiology: Volume 259: Number 3-June .2011. doi:10.1148/radiol.11100704/-/DC1
9. Nguyễn Xuân Hiền. , Nghiên cứu ứng dụng phương pháp nút động mạch tử cung trong điều trị u cơ trơn tử cung . Luận án Tiến sĩ y học, Trường Đại học Y Hà Nội 2011.
10. Phạm Gia Khánh. Nghiên cứu ứng dụng và phát triển kỹ thuật can thiệp nội mạch điều trị một số bệnh. chương trình khoa học và công nghệ trọng điểm cấp nhà nước KC10/06-10. 2010: 325-359
11. Robert A. Bucek1 Stefan Puchner Johannes Lammer” Mid- and Long-Term Quality-of-Life Assessment in Patients Undergoing Uterine Fibroid Embolization”Received November 14, 2004; accepted after revision February 7, 2005.
12. Gale Harding*†1, Karin S Coyne†1, Christine L Thompson†1 and James B Spies” The responsiveness of the uterine fibroid symptom and health-related quality of life questionnaire (UFS-QOL)’
13. Spies JB, Myers ER, Worthington-Kirsch R, Mulgund J, Goodwin S, Mauro M: The FIBROID Registry: symptom and quality-of-life status 1 year after therapy. Obstet Gynecol. 2005; 106(6):1309-1318
14. Worthington-Kirsch RL, Popky GL, Hutchins FL. Uterine arterial embolization for the management of leiomyoas: quality of life assessment and clinical respons. Radiology 1998; 208: 625-629